DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application
Authors
Keywords
-
Journal
Clinical Epigenetics
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-08-27
DOI
10.1186/s13148-021-01154-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypomethylating Agents and Immunotherapy: Therapeutic Synergism in Acute Myeloid Leukemia and Myelodysplastic Syndromes
- (2021) Kah Keng Wong et al. Frontiers in Oncology
- Exposing Hidden Targets: Combining epigenetic and immunotherapy to overcome cancer resistance
- (2020) Kelly Olino et al. SEMINARS IN CANCER BIOLOGY
- Combination of Decitabine and Entinostat Synergistically Inhibits Urothelial Bladder Cancer Cells via Activation of FoxO1
- (2020) Chenyin Wang et al. Cancers
- Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation
- (2020) Clemens Zwergel et al. Cancers
- DNA Methyltransferases in Cancer: Biology, Paradox, Aberrations, and Targeted Therapy
- (2020) Jiayu Zhang et al. Cancers
- DNA Methylation as a Therapeutic Target for Bladder Cancer
- (2020) Sandra P. Nunes et al. Cells
- Combined inhibition of JAK1/2 and DNMT1 by newly identified small-molecule compounds synergistically suppresses the survival and proliferation of cervical cancer cells
- (2020) Shiqi She et al. Cell Death & Disease
- ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma
- (2019) Hao Peng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- Low doses of decitabine improve the chemotherapy efficacy against basal-like bladder cancer by targeting cancer stem cells
- (2019) Mingqing Wu et al. ONCOGENE
- Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice
- (2019) Yuan Wei et al. GASTROENTEROLOGY
- Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma
- (2019) Xiaojuan Shi et al. BIOMEDICINE & PHARMACOTHERAPY
- Addition of Low-Dose Decitabine to Anti–PD-1 Antibody Camrelizumab in Relapsed/Refractory Classical Hodgkin Lymphoma
- (2019) Jing Nie et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells
- (2019) Clemens Zwergel et al. Clinical Epigenetics
- Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia
- (2019) Woonbok Chung et al. Clinical Epigenetics
- Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial
- (2019) Guillermo Garcia-Manero et al. Lancet Haematology
- Guadecitabine (SGI-110): an investigational drug for the treatment of myelodysplastic syndrome and acute myeloid leukemia
- (2019) Georgina S. Daher-Reyes et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways
- (2019) Hiroshi Moro et al. Gastric Cancer
- The emerging role of epigenetic therapeutics in immuno-oncology
- (2019) Michael J. Topper et al. Nature Reviews Clinical Oncology
- Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
- (2019) Emmanuel S. Antonarakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164
- (2019) Dung T. Le et al. JOURNAL OF CLINICAL ONCOLOGY
- Temporal DNA methylation pattern and targeted therapy in colitis-associated cancer
- (2019) Junshu Li et al. CARCINOGENESIS
- Promoter hypermethylation of the CFTR gene as a novel diagnostic and prognostic marker of breast cancer
- (2019) Kaisheng Liu et al. CELL BIOLOGY INTERNATIONAL
- Correction to: Low-dose decitabine enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by re-modulating the tumor microenvironment
- (2019) Ganjun Yu et al. Cellular & Molecular Immunology
- Phase I Study of CC-486 Alone and in Combination With Carboplatin or nab‑paclitaxel in Patients With Relapsed or Refractory Solid Tumors
- (2018) Daniel D. Von Hoff et al. CLINICAL CANCER RESEARCH
- Phase Ib/II study of safety and efficacy of low-dose decitabine-primed chemoimmunotherapy in patients with drug-resistant relapsed/refractory alimentary tract cancer
- (2018) Meixia Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Decitabine demonstrates antileukemic activity in B cell precursor acute lymphoblastic leukemia with MLL rearrangements
- (2018) C. Roolf et al. Journal of Hematology & Oncology
- Decitabine augments cytotoxicity of cisplatin and doxorubicin to bladder cancer cells by activating hippo pathway through RASSF1A
- (2018) Madhuram Khandelwal et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy
- (2018) Maria Cristina Manara et al. MOLECULAR CANCER THERAPEUTICS
- DNA methylation enzyme inhibitor RG108 suppresses the radioresistance of esophageal cancer
- (2018) Yao Ou et al. ONCOLOGY REPORTS
- Nucleosidic DNA demethylating epigenetic drugs – A comprehensive review from discovery to clinic
- (2018) Khushboo Agrawal et al. PHARMACOLOGY & THERAPEUTICS
- Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells
- (2018) Luc Gailhouste et al. Cell Death & Disease
- Differential sensitization of two human colon cancer cell lines to the antitumor effects of irinotecan combined with 5-aza-2'-deoxycytidine
- (2018) Shuko Hakata et al. Oncology Letters
- The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest
- (2018) Yan Zhang et al. Clinical Epigenetics
- DNMTs inhibitor SGI‑1027 induces apoptosis in Huh7 human hepatocellular carcinoma cells
- (2018) Ning Sun et al. Oncology Letters
- Mutual regulation of microRNAs and DNA methylation in human cancers
- (2017) Sumei Wang et al. Epigenetics
- Emerging therapies for acute myeloid leukemia
- (2017) Caner Saygin et al. Journal of Hematology & Oncology
- Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study
- (2017) Yousef Zakharia et al. Oncotarget
- PD-L1 promoter methylation mediates the resistance response to anti-PD-1 therapy in NSCLC patients with EGFR-TKI resistance
- (2017) Yan Zhang et al. Oncotarget
- DNA Hypomethylating Drugs in Cancer Therapy
- (2017) Takahiro Sato et al. Cold Spring Harbor Perspectives in Medicine
- Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities
- (2017) Goran Micevic et al. Clinical Epigenetics
- The safety, efficacy, and treatment outcomes of a combination of low-dose decitabine treatment in patients with recurrent ovarian cancer
- (2017) Yan Zhang et al. OncoImmunology
- Epigenetic Therapeutics: A New Weapon in the War Against Cancer
- (2016) Nita Ahuja et al. Annual Review of Medicine
- Combining Epigenetic and Immunotherapy to Combat Cancer
- (2016) Katherine B. Chiappinelli et al. CANCER RESEARCH
- Zebularine enhances apoptosis of human osteosarcoma cells by suppressing methylation ofARHI
- (2016) Kaishan Ye et al. CANCER SCIENCE
- In vitro study of human mutL homolog 1 hypermethylation in inducing drug resistance of esophageal carcinoma
- (2016) Y. Cao et al. IRISH JOURNAL OF MEDICAL SCIENCE
- Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter
- (2016) X Qu et al. ONCOGENE
- DNA demethylation and invasive cancer: implications for therapeutics
- (2015) David Cheishvili et al. BRITISH JOURNAL OF PHARMACOLOGY
- KRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine
- (2015) M. L. Stewart et al. CANCER RESEARCH
- A Unique Gene Regulatory Network Resets the Human Germline Epigenome for Development
- (2015) Walfred W.C. Tang et al. CELL
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- Low Dose Decitabine Combined with Taxol and Platinum Chemotherapy to Treat Refractory/Recurrent Ovarian Cancer: An Open-Label, Single-Arm, Phase I/II Study
- (2015) Xiaoyu Fu et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Decitabine: a promising epi-immunotherapeutic agent in solid tumors
- (2015) Xiang Li et al. Expert Review of Clinical Immunology
- Function and information content of DNA methylation
- (2015) Dirk Schübeler NATURE
- NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
- (2015) Aaron P Rapoport et al. NATURE MEDICINE
- Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4′-thio-2′-deoxycytidine and 5-aza-4′-thio-2′-deoxycytidine
- (2014) Jaideep V. Thottassery et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Decitabine, a new star in epigenetic therapy: the clinical application and biological mechanism in solid tumors
- (2014) Jing Nie et al. CANCER LETTERS
- Design, Synthesis and Biological Evaluation of 4-Amino-N-(4-aminophenyl)benzamide Analogues of Quinoline-Based SGI-1027 as Inhibitors of DNA Methylation
- (2014) Elodie Rilova et al. ChemMedChem
- Epigenetic reprogramming modulates malignant properties of human liver cancer
- (2014) Chiara Raggi et al. HEPATOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- New Insights on the Mechanism of Quinoline-based DNA Methyltransferase Inhibitors
- (2014) Christina Gros et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identifying Novel Selective Non-Nucleoside DNA Methyltransferase 1 Inhibitors through Docking-Based Virtual Screening
- (2014) Shijie Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- 1,3,4-Oxadiazole-Containing Histone Deacetylase Inhibitors: Anticancer Activities in Cancer Cells
- (2014) Sergio Valente et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective Non-nucleoside Inhibitors of Human DNA Methyltransferases Active in Cancer Including in Cancer Stem Cells
- (2014) Sergio Valente et al. JOURNAL OF MEDICINAL CHEMISTRY
- Properly Substituted Analogues of BIX-01294 Lose Inhibition of G9a Histone Methyltransferase and Gain Selective Anti-DNA Methyltransferase 3A Activity
- (2014) Dante Rotili et al. PLoS One
- Combination of Gefitinib and DNA Methylation Inhibitor Decitabine Exerts Synergistic Anti-Cancer Activity in Colon Cancer Cells
- (2014) Yun-feng Lou et al. PLoS One
- Combination Effect of Epigenetic Regulation and Ionizing Radiation in Colorectal Cancer Cells
- (2014) Joong-Gook Kim et al. PLoS One
- Low-Dose Decitabine-Based Chemoimmunotherapy for Patients with Refractory Advanced Solid Tumors: A Phase I/II Report
- (2014) Hui Fan et al. Journal of Immunology Research
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- A phase I/II study of decitabine in combination with panitumumab in patients with wild-type (wt) KRAS metastatic colorectal cancer
- (2013) I. Garrido-Laguna et al. INVESTIGATIONAL NEW DRUGS
- Synthesis and Evaluation of Analogues of N-Phthaloyl-l-tryptophan (RG108) as Inhibitors of DNA Methyltransferase 1
- (2013) Saâdia Asgatay et al. JOURNAL OF MEDICINAL CHEMISTRY
- Blockade of DNA methylation enhances the therapeutic effect of gefitinib in non-small cell lung cancer cells
- (2013) XIAO-YOU LI et al. ONCOLOGY REPORTS
- Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells
- (2012) Hsing-Chen Tsai et al. CANCER CELL
- MG98, a Second-Generation DNMT1 Inhibitor, in the Treatment of Advanced Renal Cell Carcinoma
- (2012) Robert J. Amato et al. CANCER INVESTIGATION
- Epigenetic Resensitization to Platinum in Ovarian Cancer
- (2012) D. Matei et al. CANCER RESEARCH
- The BRAFV600E causes widespread alterations in gene methylation in the genome of melanoma cells
- (2012) Peng Hou et al. CELL CYCLE
- Role of CpG context and content in evolutionary signatures of brain DNA methylation
- (2012) Yurong Xin et al. Epigenetics
- Relationship Between Chromatin Structure and Sensitivity to Molecularly Targeted Auger Electron Radiation Therapy
- (2012) Samantha Y.A. Terry et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers
- (2012) Jiyeon Yun et al. LABORATORY INVESTIGATION
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer-Type Regulation of MIG-6 Expression by Inhibitors of Methylation and Histone Deacetylation
- (2012) Yu-Wen Zhang et al. PLoS One
- Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients
- (2012) K. Odunsi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer epigenetics: linking basic biology to clinical medicine
- (2011) Hsing-Chen Tsai et al. CELL RESEARCH
- Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphomas
- (2011) Anastasios Stathis et al. CLINICAL CANCER RESEARCH
- γ-radiation induces cellular sensitivity and aberrant methylation in human tumor cell lines
- (2011) Ashok Kumar et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Molecular dynamics simulations of human DNA methyltransferase 3B with selective inhibitor nanaomycin A
- (2011) Thomas Caulfield et al. JOURNAL OF STRUCTURAL BIOLOGY
- A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer
- (2010) Fang Fang et al. CANCER
- Identification of Hypermethylated Genes Associated with Cisplatin Resistance in Human Cancers
- (2010) Xiaofei Chang et al. CANCER RESEARCH
- Nanaomycin A Selectively Inhibits DNMT3B and Reactivates Silenced Tumor Suppressor Genes in Human Cancer Cells
- (2010) D. Kuck et al. MOLECULAR CANCER THERAPEUTICS
- BCR–ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients
- (2010) D D De Carvalho et al. ONCOGENE
- Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: A children's oncology group study
- (2010) Rani E. George et al. PEDIATRIC BLOOD & CANCER
- Epigenetic regulation of latent Epstein–Barr virus promoters
- (2009) Maria Takacs et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- A New Class of Quinoline-Based DNA Hypomethylating Agents Reactivates Tumor Suppressor Genes by Blocking DNA Methyltransferase 1 Activity and Inducing Its Degradation
- (2009) J. Datta et al. CANCER RESEARCH
- Phase I Study of MG98, an Oligonucleotide Antisense Inhibitor of Human DNA Methyltransferase 1, Given as a 7-Day Infusion in Patients with Advanced Solid Tumors
- (2009) R. Plummer et al. CLINICAL CANCER RESEARCH
- Human DNA methylomes at base resolution show widespread epigenomic differences
- (2009) Ryan Lister et al. NATURE
- Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
- (2008) Carlo Stresemann et al. INTERNATIONAL JOURNAL OF CANCER
- Convergence of Mutation and Epigenetic Alterations Identifies Common Genes in Cancer That Predict for Poor Prognosis
- (2008) Timothy A Chan et al. PLOS MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now